[Stiff-person syndrome].
Sakai
Koichiro
K
Department of Neurology, Kanazawa Medical University.
D000818:Animals; D001323:Autoantibodies; D015551:Autoimmunity; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology; D003937:Diagnosis, Differential; D003975:Diazepam / Q000627:therapeutic use; D018682:GABA Agents / Q000627:therapeutic use; D005968:Glutamate Decarboxylase / Q000276:immunology / Q000502:physiology; D006801:Humans; D009046:Motor Neurons / Q000502:physiology; D009419:Nerve Tissue Proteins / Q000276:immunology; D011379:Prognosis; D016750:Stiff-Person Syndrome / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D009435:Synaptic Transmission / Q000502:physiology; D014635:Valproic Acid / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D001323:Autoantibodies; D018682:GABA Agents; D009419:Nerve Tissue Proteins; C075637:amphiphysin; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D005968:Glutamate Decarboxylase; D003975:Diazepam